论文信息 - Phase I study of YM155, a first-in-class survivin suppressant, in patients with advanced solid tumors in Japan - 字舞流文

Phase I study of YM155, a first-in-class survivin suppressant, in patients with advanced solid tumors in Japan

M. Fukuoka | T. Satoh | Y. Hasegawa | I. Okamoto | A. Tsuya | S. Ueda | K. Nakagawa | M. Miyazaki | R. Morinaga | M. Terashima